1264926-40-0

Basic information

• Product Name: C₁₂H₁₁ClN₂O
• Synonyms: C₁₂H₁₁ClN₂O
• CAS NO: 1264926-40-0
• Molecular Weight: 234.685
• Mol File: 1264926-40-0.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: C₁₂H₁₁ClN₂O(CAS DataBase Reference)
• NIST Chemistry Reference: C₁₂H₁₁ClN₂O(1264926-40-0)
• EPA Substance Registry System: C₁₂H₁₁ClN₂O(1264926-40-0)

Safety Data

• Hazardous Substances Data: 1264926-40-0(Hazardous Substances Data)

Upstream product

• 5720-05-8 4-methylphenylboronic acid 
• 5018-38-2 4,6-dichloro-5-methoxypyrimidine 

Downstream Products

• 1264927-42-5 5-hydroxy-6-p-tolylpyrimidine-4-carbonitrile 
• 1264925-85-0 1,1-dimethylethyl 4-[[5-methoxy-6-(4-methylphenyl)-4-pyrimidinyl]amino]-1-piperidinecarboxylate 
• 1264924-62-0 5-[[5-methoxy-6-(4-methylphenyl)-4-pyrimidinyl]amino]-2-pyridinecarbonitrile 
• 1264924-32-4 1,1-dimethylethyl 1,3-dihydro-5-[[5-methoxy-6-(4-methylphenyl)-4-pyrimidinyl]amino]-2H-isoindole-2-carboxylate 
• 1264924-35-7 4-[(2,3-dihydro-1H-isoindol-5-yl)amino]-6-(4-methylphenyl)-5-pyrimidinol 
• 1264927-50-5 2-(5-hydroxy-6-p-tolylpyrimidin-4-yl)-1H-benzo[d]imidazole-5-carbonitrile 
• 1264927-48-1 5-(benzyloxy)-6-p-tolylpyrimidine-4-carboxylic acid 
• 1264927-46-9 benzyl 5-(benzyloxy)-6-p-tolylpyrimidine-4-carboxylate 
• 1264927-44-7 5-hydroxy-6-p-tolylpyrimidine-4-carboxylic acid 
• 1264926-28-4 2-(5-hydroxy-6-p-tolylpyrimidin-4-yl)-1H-benzo[d]imidazole-5-carboximidamide 
• 1264924-47-1 4-[(2,3-dihydro-1-imino-1H-isoindol-5-yl)amino]-6-(4-methylphenyl)-5-pyrimidinol 
• 1264924-50-6 2,3-dihydro-1-imino-N-[5-methoxy-6-(4-methylphenyl)-4-pyrimidinyl]-1H-isoindol-5-amine 
• 1264926-49-9 C₃₀H₃₅N₅O₅ 
• 1264926-63-7 C₁₉H₁₄ClN₃O₂ 

Relevant articles and documents

Discovery of hydroxy pyrimidine Factor IXa inhibitors

The synthesis and structure activity relationship development of a pyrimidine series of heterocyclic Factor IXa inhibitors is described. Increased selectivity over Factor Xa inhibition was achieved through SAR expansion of the P1 element. Select compounds were evaluated in vivo to assess their plasma levels in rat.